11
TITLE: Absorption, metabolism and excretion of opicapone in human healthy volunteers  Full Text
AUTHORS: Loureiro, Ana, I; Rocha, Francisco; Santos, Ana T.; Singh, Nand; Bonifacio, Maria Joao; Pinto, Rui; Kiss, Laszlo E.; Soares da Silva, Patricio ;
PUBLISHED: 2022, SOURCE: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, VOLUME: 88, ISSUE: 10
INDEXED IN: Scopus WOS CrossRef: 3
12
TITLE: Effect of Opicapone on Levodopa Pharmacokinetics in Patients with Fluctuating Parkinson's Disease
AUTHORS: Ferreira, Joaquim J. ; Poewe, Werner; Rascol, Olivier; Stocchi, Fabrizio; Antonini, Angelo; Moreira, Joana; Guimaraes, Bruno; Rocha, Jose Francisco; Soares da Silva, Patricio ;
PUBLISHED: 2022, SOURCE: MOVEMENT DISORDERS, VOLUME: 37, ISSUE: 11
INDEXED IN: Scopus WOS CrossRef: 12
13
TITLE: Opicapone as an Add-on to Levodopa in Patients with Parkinson's Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON Trial
AUTHORS: Ferreira, Joaquim J. ; Poewe, Werner; Rascol, Olivier; Stocchi, Fabrizio; Antonini, Angelo; Moreira, Joana; Pereira, Ana; Rocha, Jose Francisco; Soares da Silva, Patricio ;
PUBLISHED: 2022, SOURCE: NEUROLOGY AND THERAPY, VOLUME: 11, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef: 5
14
TITLE: Opicapone Use in Clinical Practice across Germany: A Sub-Analysis of the OPTIPARK Study in Parkinson's Disease Patients with Motor Fluctuations
AUTHORS: Reichmann, Heinz; Eggert, Karla; Oehlwein, Christian; Warnecke, Tobias; Lees, Andrew J.; Kemmer, Michael; Soares da Silva, Patricio ;
PUBLISHED: 2022, SOURCE: EUROPEAN NEUROLOGY, VOLUME: 85, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 2
15
TITLE: Opicapone versus placebo in the treatment of Parkinson's disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial  Full Text
AUTHORS: Chaudhuri, KR; Odin, P; Ferreira, JJ ; Antonini, A; Rascol, O; Kurtis, MM; Storch, A; Bannister, K; Soares da Silva, P ; Costa, R; Magalhaes, D; Rocha, JF;
PUBLISHED: 2022, SOURCE: BMC NEUROLOGY, VOLUME: 22, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 8
16
TITLE: The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and II  Full Text
AUTHORS: Rocha, Jose Francisco; Ebersbach, Georg; Lees, Andrew; Tolosa, Eduardo; Ferreira, Joaquim J. ; Poewe, Werner; Rascol, Olivier; Stocchi, Fabrizio; Antonini, Angelo; Magalhaes, Diogo; Gama, Helena; Soares da Silva, Patricio ;
PUBLISHED: 2022, SOURCE: FRONTIERS IN NEUROLOGY, VOLUME: 13
INDEXED IN: Scopus WOS CrossRef: 1
17
TITLE: Antagonistic modulation of SIK1 and SIK2 isoforms in high blood pressure and cardiac hypertrophy triggered by high-salt intake  Full Text
AUTHORS: Pires, NM; Igreja, B; Soares da Silva, P ;
PUBLISHED: 2021, SOURCE: CLINICAL AND EXPERIMENTAL HYPERTENSION, VOLUME: 43, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 6
18
TITLE: Complex effects of eslicarbazepine on inhibitory micro networks in chronic experimental epilepsy  Full Text
AUTHORS: Schmidt, S; Pothmann, L; Muller Komorowska, D; Opitz, T; da Silva, PS ; Beck, H;
PUBLISHED: 2021, SOURCE: EPILEPSIA, VOLUME: 62, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 4
19
TITLE: In vitro and in vivo anti-epileptic efficacy of eslicarbazepine acetate in a mouse model of KCNQ2-related self-limited epilepsy  Full Text
AUTHORS: Monni, L; Kraus, L; Dipper Wawra, M; Soares da Silva, P ; Maier, N; Schmitz, D; Holtkamp, M; Fidzinski, P;
PUBLISHED: 2021, SOURCE: BRITISH JOURNAL OF PHARMACOLOGY, VOLUME: 179, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 7
20
TITLE: Long-term Efficacy of Opicapone in the Reduction of ON-time with Troublesome Dyskinesia in Parkinson's Disease Patients with Motor Fluctuations and Reporting Troublesome Dyskinesia
AUTHORS: Stocchi, F; Ferreira, JJ ; Klepitskaya, O; Magalhaes, D; Rocha, JF; Soares da Silva, P ;
PUBLISHED: 2021, SOURCE: NEUROLOGY, VOLUME: 96, ISSUE: 15
INDEXED IN: WOS
Page 2 of 78. Total results: 775.